PHARMACOKINETICS OF PEGLOTICASE AND METHOTREXATE POLYGLUTAMATE(S) IN PATIENTS WITH UNCONTROLLED GOUT RECEIVING PEGLOTICASE AND CO-TREATMENT OF METHOTREXATE

被引：1
|
作者：
Song, Y. [1 ]
Xin, Y. [1 ]
Weinblatt, M. E. [2 ]
Chamberlain, J. [1 ]
Obermeyer, K. [3 ]
Zhao, L. [3 ]
Canavan, C. [3 ]
Peloso, P. M. [3 ]
Ramanathan, S. [1 ]
机构：
[1] Horizon Therapeut Plc, Res & Dev, San Francisco, CA USA
[2] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA
[3] Horizon Therapeut Plc, Res & Dev, Deerfield, IL USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.2136
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1136
引用
收藏
页码：847 / 848
页数：2
相关论文
共 50 条
  • [31] PROTECT: PEGLOTICASE TREATMENT FOR UNCONTROLLED GOUT IN KIDNEY TRANSPLANTED PATIENTS; RESULTS FROM A PHASE 4 TRIAL
    Abdellatif, A.
    Zhao, L.
    Cherny, K.
    Marder, B.
    Scandling, J.
    Saag, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 908 - 909
  • [32] A Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase: 12-Month Findings
    Botson, John K.
    Saag, Kenneth
    Peterson, Jeff
    Obermeyer, Katie
    Xin, Yan
    LaMoreaux, Brian
    Padnick-Silver, Lissa
    Verma, Supra
    Grewal, Suneet
    Majjhoo, Amar
    Tesser, John R. P.
    Weinblatt, Michael E.
    ACR OPEN RHEUMATOLOGY, 2023, 5 (08) : 407 - 418
  • [33] Complete Tophus Response in Patients with Chronic Gout Initiating Pegloticase Treatment
    Becker, Michael A.
    Gonter, Neil J.
    Pope, Janet E.
    Malamet, Raymond L.
    Baraf, Herbert S. B.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S812 - S812
  • [34] Pegloticase Treatment Significantly Decreases Blood Pressure in Patients With Chronic Gout
    Johnson, Richard J.
    Choi, Hyon K.
    Yeo, Anthony E.
    Lipsky, Peter E.
    HYPERTENSION, 2019, 74 (01) : 95 - 101
  • [35] PRE-INFUSION GLUCOCORTICOID ELIMINATION IN PATIENTS WITH UNCONTROLLED GOUT TREATED WITH PEGLOTICASE: A CASE SERIES
    Newsome, V.
    Amatucci, A.
    Stainbrook, T.
    Lamoreaux, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1347 - 1348
  • [36] Predictors of Pegloticase Urate-lowering Response in the Presence and Absence of Methotrexate Co-therapy
    Mossell, James
    Duong, Mai
    Obermeyer, Katie
    Padnick-Silver, Lissa
    LaMoreaux, Brian
    Chabra, Sanjay
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2177 - 2179
  • [37] 12-month Findings of the Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled GOut Receiving Pegloticase (MIRROR RCT)
    Botson, John
    Saag, Kenneth
    Peterson, Jeff
    Obermeyer, Katie
    LaMoreaux, Brian
    Grewal, Suneet
    Majjhoo, Amar
    Tesser, John
    Weinblatt, Michael
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1 - 2
  • [38] PEGLOTICASE/METHOTREXATE CO-THERAPY IMPROVED JOINT AND PATIENT-REPORTED HEALTH ASSESSMENTS IN PATIENTS WITH UNCONTROLLED GOUT: 12-MONTH EXPLORATORY OUTCOMES OF THE MIRROR OPEN-LABEL TRIAL
    Botson, J.
    Peloso, P. M.
    Obermeyer, K.
    Lamoreaux, B.
    Zhao, L.
    Weinblatt, M. E.
    Peterson, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1348 - 1349
  • [39] A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate
    Hobl, E. -L.
    Jilma, B.
    Erlacher, L.
    Duhm, B.
    Mustak, M.
    Broell, H.
    Hoegger, P.
    Rizovski, B.
    Mader, R. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (02) : 156 - 163
  • [40] Pegloticase reduces serum urate levels in patients with treatment-refractory gout
    Nature Clinical Practice Rheumatology, 2008, 4 (12): : 624 - 624
12345